000
| 02664cam 2200481zi 4500 |
---|
001 | 9.876429 |
---|
003 | CaOODSP |
---|
005 | 20221107164714 |
---|
006 | m o d f |
---|
007 | cr ||||||||||| |
---|
008 | 190717t20192019onc o f000 0 eng d |
---|
020 | |a9780660318745 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH14-330/2019E-PDF |
---|
245 | 00|aPost-opioid campaign evaluation : |bmethodological report / |cprepared for Health Canada. |
---|
246 | 17|aPre- and post- anti-stigma opioid campaign evaluation : |bmethodological report |
---|
264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2019. |
---|
264 | 4|c©2019 |
---|
300 | |a1 online resource (17 pages) + |e1 executive summary (3 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aTitle from cover. |
---|
500 | |aIssued also in HTML format. |
---|
500 | |a"Delivery Date: July 8, 2019." |
---|
500 | |a"Supplier name: Ipsos Public Affairs." |
---|
500 | |a"Contract Number: HT372-192411/001/CY." |
---|
500 | |a"Registration number: POR 010-19." |
---|
500 | |aIssued also in French under title: Évaluation après de la campagne sur les opioïdes : rapport sur la méthodologie. |
---|
520 | |a"Health Canada has launched a multi-year advertising campaign on the subject of opioids to address stigma as a barrier to treatment, to raise awareness and understanding of the risks associated with problematic use of opioids (legal and illegal) and to help reduce problematic use, dependence and overdoses. The purpose of this research was to assess the effectiveness of the advertising campaign"--Research objectives, page 6. |
---|
650 | 0|aOpioids|zCanada|xPublic opinion. |
---|
650 | 0|aOpioid abuse|zCanada|xPublic opinion. |
---|
650 | 0|aAdvertising campaigns|zCanada|xPublic opinion. |
---|
650 | 0|aPublic opinion|zCanada. |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
710 | 2 |aIpsos (Firm). |bPublic Affairs. |
---|
775 | 08|tÉvaluation après de la campagne sur les opioïdes : |w(CaOODSP)9.876430 |
---|
856 | 40|qPDF|s527 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H14-330-2019-eng.pdf|zReport |
---|
856 | 40|qPDF|s209 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H14-330-2019-1-eng.pdf|zExecutive summary |
---|
856 | 4 |qHTML|sN/A|uhttp://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2019/010-19-e/010-19_report-rapport-eng.html|zReport |
---|
856 | 4 |qHTML|sN/A|uhttp://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2019/010-19-e/summary/010-19_summary-sommaire-eng.html|zExecutive summary |
---|